Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 2

Results: 38

Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 421, doi. 10.1177/1078155221995885

By:

Parnes, Aric;
Leblebjian, Houry;
Hamilton, Joanna;
Smith, Sydney;
Laubach, Jacob;
Berliner, Nancy

Publication type:

Article

The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 410, doi. 10.1177/1078155221995539

By:

von Grünigen, Sandrine;
Geissbühler, Antoine;
Bonnabry, Pascal

Publication type:

Article

Real-world treatment patterns in relapsed/refractory multiple myeloma: Clinical and economic outcomes in patients treated with pomalidomide or daratumumab.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 395, doi. 10.1177/1078155221995532

By:

Richter, Joshua;
Anupindi, Vamshi Ruthwik;
Yeaw, Jason;
Kudaravalli, Suneel;
Zavisic, Stojan;
Shah, Drishti

Publication type:

Article

Use of sublingual tacrolimus in adults undergoing hematopoietic cell transplant: A pilot study.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 387, doi. 10.1177/1078155221995230

By:

May, Heather P;
Bartoo, Gabriel T;
Wolf, Robert C;
Shah, Mithun V;
Litzow, Mark R;
Hogan, William J;
Alkhateeb, Hassan

Publication type:

Article

Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 381, doi. 10.1177/1078155221994319

By:

Booth, Jennifer P;
Kennerly-Shah, Julie M;
Hartman, Amber D

Publication type:

Article

Adherence to thalidomide in patients with multiple myeloma: A cross-sectional study in a Brazilian metropolis.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 373, doi. 10.1177/1078155221993528

By:

Silveira, Lívia Pena;
Pádua, Cristiane A Menezes de;
Drummond, Paula Lana de Miranda;
Malta, Jéssica Soares;
Santos, Roberta M Marques dos;
Costa, Naiane Lima;
Machado, Taísa R Lopes;
Hauck, Lucas Motta;
Reis, Adriano Max Moreira

Publication type:

Article

Increasing pharmacy productivity and reducing medication turnaround times in an Italian comprehensive cancer center by implementing robotic chemotherapy drugs compounding.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 353, doi. 10.1177/1078155221992851

By:

Capilli, Martina;
Enrico, Fiorenza;
Federici, Matteo;
Comandone, Tiziana

Publication type:

Article

Robotic chemotherapy compounding: A multicenter productivity approach.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 362, doi. 10.1177/1078155221992841

By:

Riestra, Ana C;
López-Cabezas, Carmen;
Jobard, Marion;
Campo, Mertxe;
Tamés, María J;
Marín, Ana M;
Brandely-Piat, Marie L;
Carcelero-San Martín, Esther;
Batista, Rui;
Cajaraville, Gerardo

Publication type:

Article

Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 343, doi. 10.1177/1078155221992103

By:

Chabut, Claire;
Tanguay, Cynthia;
Gagné, Sébastien;
Caron, Nicolas;
Bussières, Jean-François

Publication type:

Article

Design and stability of pediatric oral formulation of imatinib.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 337, doi. 10.1177/1078155221991200

By:

Hinterlang, Mélanie;
Gendron, Amandine;
Fleury, Thomas;
Rieutord, André;
Vrana, Anastasia;
Schlatter, Joël;
Annereau, Maxime

Publication type:

Article

Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 326, doi. 10.1177/1078155221989420

By:

Visacri, Marília B;
Duarte, Natalia C;
Lima, Tácio de M;
de Souza, Rafael N;
Cobaxo, Thiago S;
Teixeira, João CC;
Barbosa, Cristina R;
Dias, Lara P;
Tavares, Mariane GR;
Pincinato, Eder de C;
Lima, Carmen SP;
Moriel, Patricia

Publication type:

Article

PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 310, doi. 10.1177/1078155221989404

By:

Jahangiri, Rosa;
Mosaffa, Fatemeh;
Emami Razavi, Amirnader;
Teimoori-Toolabi, Ladan;
Jamialahmadi, Khadijeh

Publication type:

Article

Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 516, doi. 10.1177/10781552211061183

By:

Gündoğdu, Yasemin;
Deniz, Orhan Cem;
Saka, Didem;
Şişman, Gürhan;
Erdamar, Sibel;
Köksal, İftihar

Publication type:

Article

Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 508, doi. 10.1177/10781552211052564

By:

Sakran, Razan;
Milo, Gai;
Jabareen, Ali;
Artul, Tareq;
Haim, Nissim;
Litvak, Michael;
Ringelstein-Harlev, Shimrit;
Horowitz, Nethanel;
Efrati, Edna;
Assady, Suheir;
Kurnik, Daniel

Publication type:

Article

Aplastic anemia secondary to tyrosine kinase inhibitor therapy in a patient with chronic myeloid leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 504, doi. 10.1177/10781552211052030

By:

Kassar, Olfa;
Mallek, Rahma;
Ben Said, Fatma;
Kallel, Faten;
Ksouda, Kamilia;
Khabir, Abdelmajid;
Elloumi, Moez

Publication type:

Article

Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 500, doi. 10.1177/10781552211049728

By:

Iltar, Utku;
Alhan, Fadime Nurcan;
Vural, Ece;
Ataş, Ünal;
Sözel, Hasan;
Doğan, Ömer;
Boduroğlu, Ahmet;
Yücel, Orhan Kemal;
Salim, Ozan;
Ündar, Levent

Publication type:

Article

Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective change.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 438, doi. 10.1177/10781552211045362

By:

Giuliani, Jacopo;
Infante, Maurizio Valentino;
Micheletto, Claudio;
Bonetti, Andrea

Publication type:

Article

The cost-effectiveness of new first-line therapies approved in advanced hepatocellular carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 434, doi. 10.1177/10781552211045013

By:

Giuliani, Jacopo;
Mantoan, Beatrice;
Bonetti, Andrea

Publication type:

Article

Capecitabine induced fingerprint loss: Case report and review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 495, doi. 10.1177/10781552211045009

By:

Deneken-Hernandez, Zuratzi;
Cherem-Kibrit, Marcos;
Gutiérrez-Andrade, Luis;
Rodríguez-Gutiérrez, Georgina;
Colmenero-Mercado, Juan Oswaldo

Publication type:

Article

Elevated serum creatine kinase levels due to osimertinib: A case report and review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 489, doi. 10.1177/10781552211042271

By:

Sugimoto, Hiroshi;
Matsumoto, Satoshi;
Tsuji, Yukio;
Sugimoto, Keisuke

Publication type:

Article

Dangerous interaction of bitter melon (Momordica charantia) with pazopanib: A case of acute pancreatitis.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 486, doi. 10.1177/10781552211040725

By:

Unsal, Oktay;
Sütcüoğlu, Osman;
Yazıcı, Ozan

Publication type:

Article

A successful initiation of treatment of Hodgkin's lymphoma with adriamycin-bleomycin-vinblastine-dacarbazine dose reduction in a patient with fulminant hepatic failure and co-infection with human immunodeficiency virus and hepatitis B.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 479, doi. 10.1177/10781552211040182

By:

Veeraballi, Sindhusha;
Chan, Kok H;
Slim, Jihad;
Shaaban, Hamid S;
Guron, Gunwant

Publication type:

Article

Sustained erythrocytosis due to the use of Lenvatinib.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 475, doi. 10.1177/10781552211039108

By:

Kaur, Jaspreet;
Tuler, Shahaf;
Dasanu, Constantin A

Publication type:

Article

Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 471, doi. 10.1177/10781552211038899

By:

Wong, Pui Yee;
How, Soon Hin;
Ismail, Irnani;
Hassan, Radhiana

Publication type:

Article

Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 466, doi. 10.1177/10781552211038246

By:

Gilbar, Peter J;
Pokharel, Khageshwor

Publication type:

Article

Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient?

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 462, doi. 10.1177/10781552211038136

By:

Özyurt, Esra;
Özçelik, Serhat;
Sürmeli, Heves;
Çelik, Mehmet;
Ayhan, Murat;
Özçelik, Melike

Publication type:

Article

Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 457, doi. 10.1177/10781552211038031

By:

Giani, Jasmine;
Chambers, Carole R;
Sawyer, Michael B

Publication type:

Article

Lenalidomide-induced arthritis: A case report and review of literature and pharmacovigilance databases.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 453, doi. 10.1177/10781552211038001

By:

Icard, Charlotte;
Mocquot, Pauline;
Nogaro, Jean-Claude;
Despas, Fabien;
Gauthier, Martin

Publication type:

Article

Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 449, doi. 10.1177/10781552211035120

By:

Tekinalp, Atakan;
Kars, Taha U;
Dikici, Hatice Z;
Yılmaz, Pınar D;
Demircioğlu, Sinan;
Çeneli, Özcan

Publication type:

Article

A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 445, doi. 10.1177/10781552211031304

By:

Demir, Emre;
Sütcüoğlu, Osman;
Demir, Beril;
Ünsal, Oktay;
Yazıcı, Ozan

Publication type:

Article

Acute gout flare of bilateral first metatarsophalangeal joints due to ibrutinib use in chronic lymphocytic leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 442, doi. 10.1177/10781552211029703

By:

Kaur, Jaspreet;
Tuler, Shahaf;
Dasanu, Constantin A

Publication type:

Article

Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 425, doi. 10.1177/10781552211001928

By:

Ailawadhi, Sikander;
Swaika, Abhisek;
Advani, Pooja;
Hodge, David;
Paulus, Aneel;
Khera, Nandita;
Hashmi, Shahrukh K;
Alegria, Victoria R;
Abdulazeez, Mays;
Bodepudi, Srilekha;
Jamwal, Khushi;
Roy, Vivek;
Sher, Taimur;
Chanan-Khan, Asher;
Ailawadhi, Meghna

Publication type:

Article

Impact of oncology pharmacist services on humanistic outcome in patients with breast cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 302, doi. 10.1177/1078155220988333

By:

Khadela, Avinash;
Bhikadiya, Vishal;
Vyas, Bhavin

Publication type:

Article

Quantitative association of educational status and effect of patient counseling among cancer patients: A cross-sectional analysis in a tertiary care hospital in South India.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 296, doi. 10.1177/1078155220988115

By:

Jyoti, Kumar;
Manjula, Gudhoor;
Ganachari, Madiwalayya S

Publication type:

Article

Outpatient fractionated ICE protocol in relapsed/refractory lymphomas: Efficacy and safety.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 287, doi. 10.1177/1078155220988062

By:

Dada, Reyad;
Abdelghani, Ehab Mosaad;
Boubakra, Tarek;
Vayani, Jaweed;
Yousof, Osama;
Heaphy, Emily L Goldman;
Nawaz, Azhar

Publication type:

Article

Complementary and alternative medicine (CAM) in Turkish cutaneous melanoma patients: A prospective study from tertiary cancer center.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 282, doi. 10.1177/1078155220987637

By:

Tas, Faruk;
Cinar, Ebru;
Erturk, Kayhan

Publication type:

Article

Evaluating the incidence of engraftment syndrome with different melphalan formulations in adult multiple myeloma and immunoglobulin light chain amyloidosis patients undergoing autologous hematopoietic cell transplantation.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 274, doi. 10.1177/1078155220987623

By:

Kowalski, Kaitlyn E;
Wheeler, Sarah E;
Adams, C Brooke;
Voils, Stacy A;
Richards, Ashley I

Publication type:

Article

Vascular endothelial growth factor inhibitor induced hypertension: Retrospective analysis of the impact of blood pressure elevations on outcomes.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 265, doi. 10.1177/1078155220985915

By:

Duco, Marissa R;
Murdock, Joshua L;
Reeves, David J

Publication type:

Article